|
Company
Profile
Backed
by a panel of experienced medical advisors and a renowned professor, CADI
SCIENTIFIC was incorporated in Singapore to harness latest technology to
develop wireless sensing and tracking devices for enhancing patient care.
With early stage investment from National University of Singapore (NUS)
Technology Holdings and Economic Development Board of Singapore’s (EDB’s)
Seeds Capital, the CADI team has successfully developed CADI SmartSenseTM,
a revolutionary product for automated patient temperature monitoring and
location tracking.
This
system has gained the seal of approval from TEC (The Enterprise Challenge),
a unit under the Prime Minister's Office that funds innovative proposals
with potential to create new value or significant improvements to the
delivery of public service. The product has been successfully piloted in the
Singapore
General
Hospital
.
Patient’s
temperature can now be measured by disc-like ThermoSENSORTM,
which wirelessly transmits temperatures to receiver nodes for
anytime/anywhere monitoring. By automatically
measuring/recording/analyzing temperatures 24/7, patients can enjoy
uninterrupted rest while nurses can concentrate on more value-adding tasks.
Patients’ locations can also be identified. Other add-on parameters
will be available for complete vital-signs monitoring.
For
accurate proximity contact tracing that is needed during pandemic outbreak,
CADI offers the state-of-the-art CADI
SmartSenseTM
Proximity Contact Tracing and Location Tracking system.
For
the consumer market, CADI currently offers an elegant clinical 2-in-1 ear
and forehead thermometer and a convenient digital blood pressure monitor.
Products:
CADI SmartSense
|
CADI T560
|
CADI BP880
|
